These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility. Brown D; Macgowan A J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143 [TBL] [Abstract][Full Text] [Related]
5. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria. Medina E; Pieper DH Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189 [TBL] [Abstract][Full Text] [Related]
6. [Multiresistant Bacteria - Antibiotic Prescription and Antibiotics of Last Resort]. Kern WV Dtsch Med Wochenschr; 2018 May; 143(9):643-650. PubMed ID: 29684931 [TBL] [Abstract][Full Text] [Related]
7. Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing. Tenover FC; Mohammed MJ; Stelling J; O'Brien T; Williams R J Clin Microbiol; 2001 Jan; 39(1):241-50. PubMed ID: 11136778 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries. Ashley EA; Lubell Y; White NJ; Turner P Trop Med Int Health; 2011 Sep; 16(9):1167-79. PubMed ID: 21707879 [TBL] [Abstract][Full Text] [Related]
9. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates]. Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774 [TBL] [Abstract][Full Text] [Related]
11. Survey of antimicrobial susceptibility testing practices of veterinary diagnostic laboratories in the United States. Brooks MB; Morley PS; Dargatz DA; Hyatt DR; Salman MD; Akey BL J Am Vet Med Assoc; 2003 Jan; 222(2):168-73. PubMed ID: 12555979 [TBL] [Abstract][Full Text] [Related]
12. Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria. Xie J; Zhao Q; Li S; Yan Z; Li J; Li Y; Mou L; Zhang B; Yang W; Miao X; Jiang X; Wang R Chem Biol Drug Des; 2017 Nov; 90(5):690-702. PubMed ID: 28371431 [TBL] [Abstract][Full Text] [Related]
13. Twenty-first Century Cures Act and Antimicrobial Susceptibility Testing: Clinical Implications in the Era of Multidrug Resistance. Humphries RM; Hindler J; Jane Ferraro M; Mathers A Clin Infect Dis; 2018 Sep; 67(7):1132-1138. PubMed ID: 29796616 [TBL] [Abstract][Full Text] [Related]
14. An antibiotic susceptibility testing trial organised as part of the United Kingdom national external microbiological quality assessment scheme. Snell JJ; Brown DF; Gardner PS J Clin Pathol; 1982 Nov; 35(11):1169-76. PubMed ID: 7142426 [TBL] [Abstract][Full Text] [Related]
15. The effect of interlaboratory variability on antimicrobial susceptibility determination. Annis DH; Craig BA Diagn Microbiol Infect Dis; 2005 Sep; 53(1):61-4. PubMed ID: 16182077 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations. Ezadi F; Ardebili A; Mirnejad R J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30541939 [TBL] [Abstract][Full Text] [Related]
17. A long journey from minimum inhibitory concentration testing to clinically predictive breakpoints: deterministic and probabilistic approaches in deriving breakpoints. Dalhoff A; Ambrose PG; Mouton JW Infection; 2009 Aug; 37(4):296-305. PubMed ID: 19629383 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group report. Wilcox MH; Dmitrieva N; Gales AC; Petukhova I; Al-Obeid S; Rossi F; M Blondeau J Future Microbiol; 2017 Dec; 12():1523-1532. PubMed ID: 28812924 [TBL] [Abstract][Full Text] [Related]
19. European standards for antibiotic susceptibility testing: towards a theoretical consensus. Baquero F Eur J Clin Microbiol Infect Dis; 1990 Jul; 9(7):492-5. PubMed ID: 2226478 [TBL] [Abstract][Full Text] [Related]
20. Towards a rational antimicrobial testing policy in the laboratory. Banaji N; Oommen S Indian J Med Microbiol; 2011; 29(3):209-12. PubMed ID: 21860098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]